A Sensitive and Simple HPLC-UV Method for Trace Level Quantification of Ethyl p-Toluenesulfonate and Methyl p-Toluenesulfonate, Two Potential Genotoxins in Active Pharmaceutical Ingredients
- PMID: 22145110
- PMCID: PMC3221504
- DOI: 10.3797/scipharm.1106-23
A Sensitive and Simple HPLC-UV Method for Trace Level Quantification of Ethyl p-Toluenesulfonate and Methyl p-Toluenesulfonate, Two Potential Genotoxins in Active Pharmaceutical Ingredients
Abstract
A sensitive and simple HPLC/UV method has been developed and validated for the determination of two potential genotoxic impurities, namely methyl p-toluenesulfonate (MPTS) and ethyl p-toluenesulfonate (EPTS) at trace levels in Pemetrexed sodium API. Applying the concept of threshold of toxicological concern (TTC), a limit of 3 ppm each for both genotoxins was calculated based on the maximum daily dose of API. A reversed phase LC method using UV detection was developed and validated. The method was found to be specific and selective for the application. The limit of detection (LOD) and limit of quantitation (LOQ) for both MPTS and EPTS was found to be 0.15 ppm (0.009 μg mL(-1)) and 0.5 ppm (0.03 μg mL(-1)), respectively, with respect to sample concentration. The calibration curves of MPTS and EPTS were linear over the concentration range from LOQ to 6 μg/mL. The method was found to be specific, precise, linear and accurate and has been successfully applied to determine the two genotoxins in commercial batches of the API.
Keywords: Active Pharmaceutical Ingredient; Daily dosage; Genotoxin; Threshold of toxicological concern; Validation.
Figures







References
-
- Griesser H, Öhrlein R, Schwab W, Ehrler R, Jäger V. 3-Nitropropanal, 3-Nitropropanol, and 3-Nitropropanal Dimethyl Acetal. Org Synth. 2004;10:577.
-
- Furuta K, Gao QZ, Yamamoto H. Chiral (Acyloxy)borane Complex-catalyzed Asymmetric Diels-Alder Reaction:(1R)-1,3,4-Trimethyl-3-cyclohexene-1-carboxaldehyde. Org Synth. 1998;9:722.
-
- Imwinkelried R, Schiess M, Seebach D. Diisopropyl (2S,3S)-2,3-O-isopropylidenetartrate. Org Synth. 1993;8:201.
-
- Müller L, Mauthe RJ, Riley CM, Andino MM, Antonis DD, Beels C, DeGeorge J, De Knaep AG, Ellison D, Fagerland JA, Frank R, Fritschel B, Galloway S, Harpur E, Humfrey CD, Jacks AS, Jagota N, Mackinnon J, Mohan G, Ness DK, O’Donovan MR, Smith MD, Vudathala G, Yotti L. A rationale for determining, testing, and controlling specific impurities in pharmaceuticals that possess potential for genotoxicity. Regul Toxicol Pharmacol. 2006;44:198–211. http://dx.doi.org/10.1016/j.yrtph.2005.12.001. - DOI - PubMed
-
- Dobo KL, Greene N, Cyr MO, Caron S, Ku WW. The application of structure-based assessment to support safety and chemistry diligence to manage genotoxic impurities in active pharmaceutical ingredients during drug development. Regul Toxicol Pharmacol. 2006;44:282–93. http://dx.doi.org/10.1016/j.yrtph.2006.01.004. - DOI - PubMed
LinkOut - more resources
Full Text Sources